Lena Bronge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lena Bronge has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Lars-Olof Wahlund
Institution of NEUROTEC, Division of Geriatric Medicine, Karolinska Institutet, Huddinge University Hospital, SE-141 86 Stockholm, Sweden
4 shared publicationsBengt Isberg
1 shared publicationIrina Savitcheva
1 shared publicationLars Lannfelt
1 shared publication- Lars-Olof Wahlund
Karolinska Institutet
1 shared publication Mari Blomberg
1 shared publication
Latest Publications
- 1 October 2015
- Published by Oxford University Press (OUP)
- p. 200-207
Neuroimaging in vascular cognitive impairment
- 1 October 2015
- Published by Oxford University Press (OUP)
- p. 200-207
Neuroimaging in vascular cognitive impairment
- 8 April 2003
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 122 (3) , 199-206
Prognostic significance of white matter changes in a memory clinic population
- 8 April 2003
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 122 (3) , 199-206
Prognostic significance of white matter changes in a memory clinic population
- 1 May 2002
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 13 (4) , 205-212
Postmortem MRI and Histopathology of White Matter Changes in Alzheimer Brains
To evaluate whether magnetic resonance imaging (MRI) of white matter changes in Alzheimer’s disease either under- or overestimates the findings on neuropathology. Postmortem MRI and neuropathological examination were performed on 6 brains from elderly individuals with a postmortem diagnosis of AD. Using a specially designed brain slicer, the brains were cut corresponding to the MRI images, and stained by Luxol Fast Blue. Quantitative analysis of white matter changes on MRI and neuropathology was performed using stereological principles. Measures from MRI and pathology were highly correlated (r2 = 0.71). However, pathology showed significantly more extensive changes than did MRI in all cases, with a mean of 54% larger areas. The lesions not identified with MRI represented, however, only minor changes with lower intensity of myelin staining and with an accentuation of the distance between fibres but with preserved axonal network and glial cell density.
- 1 May 2002
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 13 (4) , 205-212
Postmortem MRI and Histopathology of White Matter Changes in Alzheimer Brains
To evaluate whether magnetic resonance imaging (MRI) of white matter changes in Alzheimer’s disease either under- or overestimates the findings on neuropathology. Postmortem MRI and neuropathological examination were performed on 6 brains from elderly individuals with a postmortem diagnosis of AD. Using a specially designed brain slicer, the brains were cut corresponding to the MRI images, and stained by Luxol Fast Blue. Quantitative analysis of white matter changes on MRI and neuropathology was performed using stereological principles. Measures from MRI and pathology were highly correlated (r2 = 0.71). However, pathology showed significantly more extensive changes than did MRI in all cases, with a mean of 54% larger areas. The lesions not identified with MRI represented, however, only minor changes with lower intensity of myelin staining and with an accentuation of the distance between fibres but with preserved axonal network and glial cell density.
- 9 August 2000
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 11 (5) , 263-267
White Matter Lesions in Dementia: An MRI Study on Blood-Brain Barrier Dysfunction
White matter lesions (WMLs) and blood-brain barrier (BBB) dysfunction are common in dementia. Both conditions may be a consequence of small-vessel disease, in which case the BBB damage would be suspected to be located to the WMLs. To further evaluate the nature of WMLs in dementia we examined 10 demented patients with WMLs, including 5 cases with elevated CSF/serum albumin ratios as an indication of BBB damage. An optimised gadolinium (Gd)-enhanced MRI technique was used including a double dose of Gd, a 30-min scan time after injection and analysis of the MR signal in the WMLs as a function over time. Results showed no significant changes in MR signal in the WMLs after contrast administration. We conclude that WMLs are not connected to BBB damage to such a degree that is detectable with this method and that the elevated CSF albumin might have another origin.
- 9 August 2000
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 11 (5) , 263-267
White Matter Lesions in Dementia: An MRI Study on Blood-Brain Barrier Dysfunction
White matter lesions (WMLs) and blood-brain barrier (BBB) dysfunction are common in dementia. Both conditions may be a consequence of small-vessel disease, in which case the BBB damage would be suspected to be located to the WMLs. To further evaluate the nature of WMLs in dementia we examined 10 demented patients with WMLs, including 5 cases with elevated CSF/serum albumin ratios as an indication of BBB damage. An optimised gadolinium (Gd)-enhanced MRI technique was used including a double dose of Gd, a 30-min scan time after injection and analysis of the MR signal in the WMLs as a function over time. Results showed no significant changes in MR signal in the WMLs after contrast administration. We conclude that WMLs are not connected to BBB damage to such a degree that is detectable with this method and that the elevated CSF albumin might have another origin.
- 26 February 1999
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 10 (2) , 89-96
White Matter Lesions in Alzheimer Patients Are Influenced by Apolipoprotein E Genotype
To analyse the influence of apolipoprotein E (APOE) genotype on the extent of white matter lesions (WMLs) in Alzheimer’s disease (AD), we examined 60 AD patients with magnetic resonance imaging. The WMLs were rated visually in different brain regions. The patients with the APOE genotype σ4/4 had more extensive WMLs in the deep white matter than patients with genotypes σ3/3 and σ3/4. There was a correlation with age for WMLs in the deep white matter in patients with the APOE σ3/3 genotype. In patients carrying at least one σ4 allele, the WMLs showed no age correlation. The results could imply that in APOE allele σ4 carriers, the WMLs represent a pathological process related to the aetiology of the disease.
- 26 February 1999
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 10 (2) , 89-96
White Matter Lesions in Alzheimer Patients Are Influenced by Apolipoprotein E Genotype
To analyse the influence of apolipoprotein E (APOE) genotype on the extent of white matter lesions (WMLs) in Alzheimer’s disease (AD), we examined 60 AD patients with magnetic resonance imaging. The WMLs were rated visually in different brain regions. The patients with the APOE genotype σ4/4 had more extensive WMLs in the deep white matter than patients with genotypes σ3/3 and σ3/4. There was a correlation with age for WMLs in the deep white matter in patients with the APOE σ3/3 genotype. In patients carrying at least one σ4 allele, the WMLs showed no age correlation. The results could imply that in APOE allele σ4 carriers, the WMLs represent a pathological process related to the aetiology of the disease.